Workday

WDAY

----

2026-W372026-09-07

WDAY.US Weekly Report · 2026-W37

Workday’s stock came under pressure this week, declining from $195.79 last Friday to $185.70, a weekly loss of 5.15%. Earnings delivery remains exceptional—Q2 EPS more than doubled sequentially with a net margin of 23.86%, well above historical averages—yet the stock adjustment reflects market skepticism toward elevated valuations. While institutional ratings stay constructive, capital outflows this week create conflicting signals worth examining.

Price Action and Technical Setup

Closing at $185.70, the stock fell $10.09 or 5.15% from the prior week’s close of $195.79. Intraweek range was tight: high of $188.57 and low of $184.27, representing only 2.2% amplitude, suggesting directional pressure rather than sharp swings. Trading volume of 1.86 million shares ($344.7 million) was normal compared to the 60-day average, with turnover of 0.96%—neither abnormally elevated nor compressed, indicating the decline was trend-driven rather than panic-driven.

Recent price action shows a notable reversal from the August mid-month peak of $227.49 (Aug 13). After a brief early-September rebound to $206.92, the stock has retreated back below $185, approaching the 60-day cost basis. The K-line pattern displays compression on the downside with limited support, characteristic of an orderly retracement.

Valuation Assessment

Current P/E of 35.77x and P/B of 6.93x place the stock at the 5.2 percentile over the past three years on P/E basis—a clear low positioning. This compression stems entirely from stock price adjustment, not earnings deterioration. Workday’s fundamentals (EPS and revenue) remain on an upward trajectory; the P/E contraction reflects relative derating, not fundamental weakness.

While historically cheap on a three-year timeframe, a P/E of 35 remains mid-to-high for software industry peers, pricing in sustained high growth and margin expansion. The recent valuation reset is more about normalizing prior gains than identifying distressed levels.

Earnings Realization

The most recent quarter (Q2 2027) delivered exceptional results:

EPS of $2.57, up 196% sequentially from $0.87 and 206% year-over-year from $0.84
Operating revenue of $2.649 billion, up 4.2% sequentially and 12.8% year-over-year, maintaining double-digit expansion
Net income of $632 million, up 185% sequentially and 177% year-over-year, hitting near-term highs
Net margin of 23.86%, dramatically improved from prior quarter’s 8.73%, approaching historical peaks

Relative to consensus expectations of $12.06 EPS annually, the Q2 contribution of $2.57 represents a quarter of full-year guidance. The sequential doubling of EPS and margin expansion—rather than a one-off beat—signals improved profit structure. This underlying quality is evident in institutional behavior: ratings remain constructive despite the week’s price decline.

Capital Flows

Capital flows turned net negative this week. Large-cap flows showed small net inflows: $185.66 in versus $139.39 out, net +$46.27. Mid-cap flows also net positive: $501.31 in versus $347.10 out, net +$154.21. However, retail flows decisively net negative: $1,699.48 in versus $2,334.77 out, net -$635.29.

Overall, retail capitulated while institutional buyers showed modest accumulation insufficient to offset redemptions. This aligns with the technical picture—measured downtrend with piecemeal institutional accumulation during weakness and retail capitulation.

Institutional Consensus

Rating distribution across 42 analyst firms: 15 strong buys, 19 holds, 5 reduces, 1 sell, 2 no rating. The consensus points to “buy” with a target price of $208.68, implying 12.4% upside from current levels.

These ratings are backward-looking lagging indicators, formed prior to this week’s decline. The divergence between constructive institutional consensus and weekly capital outflows typically signals: 1) ratings have not yet absorbed latest market risk repricing; 2) institutional recommendations lag actual portfolio actions; 3) institutional optimism on fundamentals clashes with investor skepticism on valuation.

Weekly News Highlights

This week’s news centered on management transitions, government contracts, and shareholder movements:

The narrative arc: management stabilization via new CMO appointment, followed by divergent institutional repositioning (some profit-taking from large holders, others like CalPERS accumulating weakness). This reflects genuine disagreement about valuation despite universal agreement on long-term potential.

Signal Consistency and Contradictions

The Tension:

Valuation, earnings, and ratings point to bullish—low-percentile P/E, accelerating EPS, bullish consensus. Yet capital flows and price action signal pressure—retail exodus, continued downtrend.

The root cause likely lies in normalization: high-growth expectations have partially priced in, and the $188-$196 band represents a validation zone where institutional buyers verify the 23% net margins and near-term growth before re-committing. Retail investor positioning built at $206 and $227 is now unwinding—part profit-taking, part expectation reset for slower near-term momentum. Institutional players use the weakness to rebuild, preparing for the next leg.

Implication: This week’s drawdown does not contradict the fundamental thesis (Q2 delivered proof), but marks the end of the prior momentum phase. The next inflection hinges not on earnings—already validated—but on whether valuations find footing at this low percentile and whether institutional accumulation crystallizes into renewed upside. Current signals are mixed; both risk and opportunity exist.